334 related articles for article (PubMed ID: 34139370)
41. Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis.
Dheda K; Chang KC; Guglielmetti L; Furin J; Schaaf HS; Chesov D; Esmail A; Lange C
Clin Microbiol Infect; 2017 Mar; 23(3):131-140. PubMed ID: 27756712
[TBL] [Abstract][Full Text] [Related]
42. Early detection of Pre-XDR TB with line probe assay in a high TB burden country.
Madukaji L; Okohu I; Usman S; Oyedum U; Enagi A; Usman A; Adedeji AS; Owolagba F; Ofuche E; Samuels JO; Jolayemi T; Okonkwo P
Afr Health Sci; 2021 Sep; 21(3):968-974. PubMed ID: 35222556
[TBL] [Abstract][Full Text] [Related]
43. The burden of drug resistant tuberculosis in a predominantly nomadic population in Uganda: a mixed methods study.
Simbwa BN; Katamba A; Katana EB; Laker EAO; Nabatanzi S; Sendaula E; Opio D; Ictho J; Lochoro P; Karamagi CA; Kalyango JN; Worodria W
BMC Infect Dis; 2021 Sep; 21(1):950. PubMed ID: 34521382
[TBL] [Abstract][Full Text] [Related]
44. Characteristics of Mycobacterium Tuberculosis Positive Patients Screened for Drug-Resistant Tuberculosis at a Tertiary Health Facility in Lagos, Nigeria.
Kuyinu YA; Odugbemi BA; Salisu-Olatunji SO; Adepoju FO; Odusanya OO
J Natl Med Assoc; 2018 Feb; 110(1):88-91. PubMed ID: 29510850
[TBL] [Abstract][Full Text] [Related]
45. A retrospective genomic analysis of drug-resistant strains of M. tuberculosis in a high-burden setting, with an emphasis on comparative diagnostics and reactivation and reinfection status.
Wollenberg K; Harris M; Gabrielian A; Ciobanu N; Chesov D; Long A; Taaffe J; Hurt D; Rosenthal A; Tartakovsky M; Crudu V
BMC Infect Dis; 2020 Jan; 20(1):17. PubMed ID: 31910804
[TBL] [Abstract][Full Text] [Related]
46. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010.
Zignol M; van Gemert W; Falzon D; Sismanidis C; Glaziou P; Floyd K; Raviglione M
Bull World Health Organ; 2012 Feb; 90(2):111-119D. PubMed ID: 22423162
[TBL] [Abstract][Full Text] [Related]
47. Drug resistance pattern and mutation pattern in pediatric tuberculosis: Study from north India.
Khurana P; Saigal K; Ghosh A
Indian J Tuberc; 2021 Oct; 68(4):481-484. PubMed ID: 34752317
[TBL] [Abstract][Full Text] [Related]
48. Opinion review of drug resistant tuberculosis in West Africa: tackling the challenges for effective control.
Otchere ID; Asante-Poku A; Akpadja KF; Diallo AB; Sanou A; Asare P; Osei-Wusu S; Onyejepu N; Diarra B; Dagnra YA; Kehinde A; Antonio M; Yeboah-Manu D
Front Public Health; 2024; 12():1374703. PubMed ID: 38827613
[TBL] [Abstract][Full Text] [Related]
49. Prevalence of Multi-Drug Resistant
Ali S; Khan MT; Khan AS; Mohammad N; Khan MM; Ahmad S; Noor S; Jabbar A; Daire C; Hassan F
Pol J Microbiol; 2020; 69(2):1-5. PubMed ID: 32249555
[TBL] [Abstract][Full Text] [Related]
50. Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India.
Dhakulkar S; Das M; Sutar N; Oswal V; Shah D; Ravi S; Vengurlekar D; Chavan V; Rebello L; Meneguim AC; Iyer A; Mansoor H; Kalon S; Acharya S; Ferlazzo G; Isaakidis P; Thakur HP
PLoS One; 2021; 16(2):e0246639. PubMed ID: 33600431
[TBL] [Abstract][Full Text] [Related]
51. Rates and timeliness of treatment initiation among drug-resistant tuberculosis patients in Nigeria- A retrospective cohort study.
Oga-Omenka C; Zarowsky C; Agbaje A; Kuye J; Menzies D
PLoS One; 2019; 14(4):e0215542. PubMed ID: 31022228
[TBL] [Abstract][Full Text] [Related]
52. Prevalence and genetic determinant of drug-resistant tuberculosis among patients completing intensive phase of treatment in a Tertiary Referral Center in Nigeria.
Mohammad AB; Iliyasu G; Habib AG
Int J Mycobacteriol; 2017; 6(1):47-51. PubMed ID: 28317805
[TBL] [Abstract][Full Text] [Related]
53. First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda.
Kabahita JM; Kabugo J; Kakooza F; Adam I; Guido O; Byabajungu H; Namutebi J; Namaganda MM; Lutaaya P; Otim J; Kakembo FE; Kanyerezi S; Nabisubi P; Sserwadda I; Kasule GW; Nakato H; Musisi K; Oola D; Joloba ML; Mboowa G
Antimicrob Resist Infect Control; 2022 May; 11(1):68. PubMed ID: 35550202
[TBL] [Abstract][Full Text] [Related]
54. Limited access to drugs for resistant tuberculosis: a call to action.
Bélard S; Janssen S; Osbak KK; Adegnika AA; Ondounda M; Grobusch MP
J Public Health (Oxf); 2015 Dec; 37(4):691-3. PubMed ID: 25527468
[TBL] [Abstract][Full Text] [Related]
55. Size and usage patterns of private TB drug markets in the high burden countries.
Wells WA; Ge CF; Patel N; Oh T; Gardiner E; Kimerling ME
PLoS One; 2011 May; 6(5):e18964. PubMed ID: 21573227
[TBL] [Abstract][Full Text] [Related]
56. Recent updates in diagnosis and management of drug-resistant tuberculosis in India: A paradigm shift and the way ahead during the COVID-19 crisis.
Gupta M; Ish P; Malhotra N
Indian J Tuberc; 2022 Jul; 69(3):264-267. PubMed ID: 35760475
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis.
Goyal V; Kadam V; Narang P; Singh V
BMC Public Health; 2017 Oct; 17(1):817. PubMed ID: 29041901
[TBL] [Abstract][Full Text] [Related]
58. Cross-sectional Whole-genome Sequencing and Epidemiological Study of Multidrug-resistant Mycobacterium tuberculosis in China.
Huang H; Ding N; Yang T; Li C; Jia X; Wang G; Zhong J; Zhang J; Jiang G; Wang S; Zong Z; Jing W; Zhao Y; Xu S; Chen F
Clin Infect Dis; 2019 Jul; 69(3):405-413. PubMed ID: 30321294
[TBL] [Abstract][Full Text] [Related]
59. Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs.
Zumla A; Abubakar I; Raviglione M; Hoelscher M; Ditiu L; McHugh TD; Squire SB; Cox H; Ford N; McNerney R; Marais B; Grobusch M; Lawn SD; Migliori GB; Mwaba P; O'Grady J; Pletschette M; Ramsay A; Chakaya J; Schito M; Swaminathan S; Memish Z; Maeurer M; Atun R
J Infect Dis; 2012 May; 205 Suppl 2():S228-40. PubMed ID: 22476720
[TBL] [Abstract][Full Text] [Related]
60. Tuberculosis in pregnancy.
Hui SYA; Lao TT
Best Pract Res Clin Obstet Gynaecol; 2022 Dec; 85(Pt A):34-44. PubMed ID: 36002371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
